Literature DB >> 22840852

Staphylococcus aureus α-toxin modulates skin host response to viral infection.

Lianghua Bin1, Byung Eui Kim, Anne Brauweiler, Elena Goleva, Joanne Streib, Yinduo Ji, Patrick M Schlievert, Donald Y M Leung.   

Abstract

BACKGROUND: Patients with atopic dermatitis (AD) with a history of eczema herpeticum have increased staphylococcal colonization and infections. However, whether Staphylococcus aureus alters the outcome of skin viral infection has not been determined.
OBJECTIVE: We investigated whether S aureus toxins modulated host response to herpes simplex virus (HSV) 1 and vaccinia virus (VV) infections in normal human keratinocytes (NHKs) and in murine infection models.
METHODS: NHKs were treated with S aureus toxins before incubation of viruses. BALB/c mice were inoculated with S aureus 2 days before VV scarification. Viral loads of HSV-1 and VV were evaluated by using real-time PCR, a viral plaque-forming assay, and immunofluorescence staining. Small interfering RNA duplexes were used to knockdown the gene expression of the cellular receptor of α-toxin, a disintegrin and metalloprotease 10 (ADAM10). ADAM10 protein and α-toxin heptamers were detected by using Western blot assays.
RESULTS: We demonstrate that sublytic staphylococcal α-toxin increases viral loads of HSV-1 and VV in NHKs. Furthermore, we demonstrate in vivo that the VV load is significantly greater (P < .05) in murine skin inoculated with an α-toxin-producing S aureus strain compared with murine skin inoculated with the isogenic α-toxin-deleted strain. The viral enhancing effect of α-toxin is mediated by ADAM10 and is associated with its pore-forming property. Moreover, we demonstrate that α-toxin promotes viral entry in NHKs.
CONCLUSION: The current study introduces the novel concept that staphylococcal α-toxin promotes viral skin infection and provides a mechanism by which S aureus infection might predispose the host toward disseminated viral infections.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840852      PMCID: PMC3594992          DOI: 10.1016/j.jaci.2012.06.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  48 in total

Review 1.  Bacterial infections and atopic dermatitis.

Authors:  K Breuer; A Kapp; T Werfel
Journal:  Allergy       Date:  2001-11       Impact factor: 13.146

2.  Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.

Authors:  Adam D Kennedy; Juliane Bubeck Wardenburg; Donald J Gardner; Daniel Long; Adeline R Whitney; Kevin R Braughton; Olaf Schneewind; Frank R DeLeo
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

3.  Update on emerging infections: news from the Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007.

Authors:  Bradley W Frazee
Journal:  Ann Emerg Med       Date:  2007-11       Impact factor: 5.721

4.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

5.  Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR.

Authors:  Manfred Weidmann; Ursula Meyer-König; Frank T Hufert
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

Authors:  Lisa A Beck; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon Hanifin; Rich Gallo; Amy S Paller; Susi Lieff; Jamie Reese; Daniel Zaccaro; Henry Milgrom; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2009-06-27       Impact factor: 10.793

7.  Specificity protein 1 is pivotal in the skin's antiviral response.

Authors:  Lianghua Bin; Michael D Howell; Byung Eui Kim; Joanne E Streib; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2011-01-05       Impact factor: 10.793

8.  A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice.

Authors:  Ichiro Inoshima; Naoko Inoshima; Georgia A Wilke; Michael E Powers; Karen M Frank; Yang Wang; Juliane Bubeck Wardenburg
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

9.  Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection.

Authors:  Naoko Inoshima; Yang Wang; Juliane Bubeck Wardenburg
Journal:  J Invest Dermatol       Date:  2012-03-01       Impact factor: 8.551

10.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

View more
  27 in total

1.  Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.

Authors:  Lianghua Bin; Michael G Edwards; Ryan Heiser; Joanne E Streib; Brittany Richers; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

Review 2.  Innate Antiviral Immunity in the Skin.

Authors:  Chelsea Handfield; Jeffery Kwock; Amanda S MacLeod
Journal:  Trends Immunol       Date:  2018-03-08       Impact factor: 16.687

3.  Toward an Alternative Therapeutic Approach for Skin Infections: Antagonistic Activity of Lactobacilli Against Antibiotic-Resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Mohamed M Hafez; Ibrahim A Maghrabi; Noha M Zaki
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

4.  Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions".

Authors:  Wendy F Davidson; Donald Y M Leung; Lisa A Beck; Cecilia M Berin; Mark Boguniewicz; William W Busse; Talal A Chatila; Raif S Geha; James E Gern; Emma Guttman-Yassky; Alan D Irvine; Brian S Kim; Heidi H Kong; Gideon Lack; Kari C Nadeau; Julie Schwaninger; Angela Simpson; Eric L Simpson; Jonathan M Spergel; Alkis Togias; Ulrich Wahn; Robert A Wood; Judith A Woodfolk; Steven F Ziegler; Marshall Plaut
Journal:  J Allergy Clin Immunol       Date:  2019-01-09       Impact factor: 10.793

5.  Why is eczema herpeticum unexpectedly rare?

Authors:  Donald Y M Leung
Journal:  Antiviral Res       Date:  2013-02-22       Impact factor: 5.970

Review 6.  Epithelial barrier repair and prevention of allergy.

Authors:  Elena Goleva; Evgeny Berdyshev; Donald Ym Leung
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 7.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 8.  New insights into atopic dermatitis: role of skin barrier and immune dysregulation.

Authors:  Donald Y M Leung
Journal:  Allergol Int       Date:  2013-06       Impact factor: 5.836

Review 9.  Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches.

Authors:  Donald Y M Leung; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2014-10       Impact factor: 10.793

Review 10.  Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review.

Authors:  Peck Y Ong; Donald Y M Leung
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 10.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.